Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Feb 28;4(1):57-60.
doi: 10.36518/2689-0216.1465. eCollection 2023.

Supersensitivity Psychosis with Acute Dystonia

Affiliations
Case Reports

Supersensitivity Psychosis with Acute Dystonia

Tatiana Nunez et al. HCA Healthc J Med. .

Abstract

Introduction: Supersensitivity psychosis is a phenomenon that occurs with chronic usage of antipsychotics secondary to treatment resistance. At this time, there are no standardized guidelines regarding the management of supersensitivity psychosis.

Case presentation: We present a case of a patient with schizoaffective disorder who developed supersensitivity psychosis and acute dystonia in response to discontinuing psychotropic medications, including high-dose quetiapine and olanzapine. The patient presented with excessive anxiety, paranoia, bizarre thoughts, and generalized dystonia affecting the face, trunk, and extremities. We treated the patient with olanzapine, valproic acid, and diazepam, which alleviated the psychosis back to baseline and significantly improved the dystonia. Despite compliance, the patient returned for inpatient stabilization due to depressive symptoms and worsening of the dystonia. During the second admission, the patient required further modification of psychotropics and supplemental electroconvulsive therapy.

Conclusion: In this paper, we discuss the proposed treatment of supersensitivity psychosis, including the role that electroconvulsive therapy may play in alleviating supersensitivity psychosis and associated movement disorders. We hope to expand the knowledge of additional neuromotor manifestations in supersensitivity psychosis and the management of this unique presentation.

Keywords: antipsychotic withdrawal; dopamine; dopamine supersensitivity; dystonia; electroconvulsive therapy (ECT); olanzapine; schizoaffective disorder; schizophrenia; supersensitivity psychosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest The authors declare that they have no conflicts of interest.

References

    1. Yin J, Barr AM, Ramos-Miguel A, Procyshyn RM. Antipsychotic induced dopamine supersensitivity psychosis: a comprehensive review. Curr Neuropharmacol. 2017;15(1):174–183. doi: 10.2174/1570159x14666160606093602. - DOI - PMC - PubMed
    1. Chouinard G, Samaha AN, Chouinard VA, et al. Antipsychotic-induced dopamine supersensitivity psychosis: pharmacology, criteria, and therapy. Psychother Psychosom. 2017;86(4):189–219. doi: 10.1159/000477313. - DOI - PubMed
    1. Sienaert P, van Harten P, Rhebergen D. The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia. Handb Clin Neurol. 2019;165:415–428. doi: 10.1016/B978-0-444-64012-3.00025-3. - DOI - PubMed
    1. Karaş H, Güdük M, Saatcioğlu Ö. Withdrawal-emergent dyskinesia and supersensitivity psychosis due to olanzapine use. Noro Psikiyatr Ars. 2016;53(2):178–180. doi: 10.5152/npa.2015.10122. - DOI - PMC - PubMed
    1. Peretti CS, Chouinard G. Aripiprazole combined with lamotrigine in the treatment of a treatment-resistant schizophrenic patient with tardive dyskinesia and supersensitivity psychosis. Psychother Psychosom. 2019;88(5):313–314. doi: 10.1159/000501130. - DOI - PubMed

Publication types

LinkOut - more resources